The North American Orphan Drugs Market is experiencing substantial growth due to rising awareness of rare diseases, increasing healthcare expenditures, and strong support from regulatory authorities across the region. The market benefits from the presence of leading pharmaceutical and biotechnology companies actively engaged in the development of innovative therapies for rare conditions....